Our September issue reports the discontinuation of the human trials Avigen was conducting on a new hemophilia treatment–the latest of many setbacks in the commercialization of gene therapy. But basic research in the field has continued undaunted, with results that may strike you as either astounding or terrifying, depending on how you feel about the prospect of genetically modifying your personality.
Researchers at the National Institute of Mental Health have used gene therapy to “cure” monkeys of their tendency to procrastinate. Similar treatments could eventually benefit people suffering from depression, schizophrenia, and obsessive-compulsive disorder; but they could also take the debate about the “medicalization” of psychological characteristics into a whole new arena.
Here’s how a Twitter engineer says it will break in the coming weeks
One insider says the company’s current staffing isn’t able to sustain the platform.
Technology that lets us “speak” to our dead relatives has arrived. Are we ready?
Digital clones of the people we love could forever change how we grieve.
How to befriend a crow
I watched a bunch of crows on TikTok and now I'm trying to connect with some local birds.
Starlink signals can be reverse-engineered to work like GPS—whether SpaceX likes it or not
Elon said no thanks to using his mega-constellation for navigation. Researchers went ahead anyway.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.